BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 1, 2021
View Archived Issues
New antifungals identified at Wigen Biomedicine Technology
Read More
SwanBio begins natural history study of adrenomyeloneuropathy to support SBT-101 development
Read More
Albireo describes new inhibitors of IBAT and/or NTCP
Read More
PB-201 shows safety and dose-dependent glycemic control in phase I trial
Read More
Janssen Pharmaceutica identifies new N-acetyl-beta-D-glucosaminidase inhibitors
Read More
Somatostatin SST5 receptor antagonists discovered at Kallyope
Read More
LG Chem patents sphingosine 1-phosphate receptor 1 agonists
Read More
Tissue factor knockout human placenta adherent stromal cells tested in MS model
Read More
Lilly describes first-in-human results with oxyntomodulin analogue LY-3305677
Read More
Study suggests teicoplanin can improve outcomes in COVID pneumonia patients
Read More
Retrotope initiates phase II study of RT-001 in progressive supranuclear palsy
Read More
Atea presents interim phase II data for AT-527 in hospitalized patients with COVID-19
Read More
Updated phase I/II data for galinpepimut-S plus Keytruda in WT1-positive ovarian cancer
Read More
Phase Ib data for NIS-793 plus spartalizumab in patients with advanced solid tumors
Read More
DksA1 inhibitors to suppress QS-mediated virulence of P. aeruginosa
Read More
ARO-DUX4 both prevents and reverses FSHD phenotype in mice
Read More
ISSCR: Genome-edited stem cells can make immune-evading transplants
Read More
ApoE4 allele as potential genetic risk factor for heart failure
Read More
CureVac reports final data from phase IIb/III study of COVID-19 vaccine candidate CVnCoV
Read More
Arrowhead begins dosing in phase IIb study of ARO-ANG3 in mixed dyslipidemia
Read More
Histogen opens phase I/II study of HST-003 for regeneration of knee cartilage
Read More
Pharmaxis reports inhibition of target enzymes in phase Ic study of PXS-5505 in myelofibrosis
Read More
Marinomed reports phase II topline data on Tacrosolv eye drops for allergic rhinoconjunctivitis
Read More
Oyster Point reports preclinical data on OC-01 and OC-02 against SARS-CoV-2 and variants
Read More